Cargando…
The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis
The pleiotropic benefits of statins may result from their impact on vascular inflammation. The molecular process underlying this phenomenon is not fully elucidated. Here, RNA sequencing designed to investigate gene expression patterns following CD47-SIRPα inhibition identifies a link between statins...
Autores principales: | Jarr, Kai-Uwe, Ye, Jianqin, Kojima, Yoko, Ye, Zhongde, Gao, Hua, Schmid, Sofie, Luo, Lingfeng, Baylis, Richard A., Lotfi, Mozhgan, Lopez, Nicolas, Eberhard, Anne V., Smith, Bryan Ronain, Weissman, Irving L., Maegdefessel, Lars, Leeper, Nicholas J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390974/ https://www.ncbi.nlm.nih.gov/pubmed/35990913 http://dx.doi.org/10.1038/s44161-022-00023-x |
Ejemplares similares
-
Pro-efferocytic nanoparticles are specifically taken up by lesional macrophages and prevent atherosclerosis
por: Flores, Alyssa M., et al.
Publicado: (2020) -
CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis
por: Kojima, Yoko, et al.
Publicado: (2016) -
Resolution therapy: Harnessing efferocytic macrophages to trigger the resolution of inflammation
por: Saas, Philippe, et al.
Publicado: (2022) -
Efferocytic Defects in Early Atherosclerosis Are Driven by GATA2 Overexpression in Macrophages
por: Yin, Charles, et al.
Publicado: (2020) -
Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes
por: Lam, Austin Le, et al.
Publicado: (2021)